1Jones RN.Ceftibuten:a review of antimicrobial activity,spectrum and other microbiologic features.Pediatr Infect Dis J,1993,12(Suppl):37-44. 被引量：1
2Jons RN.Antimicrobial activity and spectrum of ceftibuten,a review of United States and Canadian results.Diagn Microbiol Infect Dis,1991,14(1):37-43. 被引量：1
3Wiseman LR,Balfour JA.Ceftibuten:a review of its antibacterial activity,pharmacokinetic properties and clinical efficacy.Drugs,1999,47(4):784-808. 被引量：1
4Wise R,Andrews JM,Ashby JP,et al.Ceftibuten:a new orally absorbed cephalosporin,in vitro activity against strains from the United Kingdom.Diagn Microbiol Infect Dis,1991,14(1):45-52. 被引量：1
5Barr WH,Lin CC,Radwanskl E,et al.The pharmacokinetics of ceftibuten in humans.Diagn Microbiol Infect Dis,1991,14(1):93-100. 被引量：1
6McCake R,Rumans L,Perrotta R,et al.Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.J Chemother,1993,5(1):124-132. 被引量：1
5Vilaichone A, Watana D, Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children [ J ]. J Med Assoc Thai, 2001,84( Suppl 1 ) :S61-67 被引量：1
6Fernandez P, San Martin L. Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy [J]. Rev Med Chil, 2000,128(3) :267-272 被引量：1
7Szekely E, Ludwig E. Effectiveness of ceftibuten in the sequential therapy of respiratory and urinary tract infections [J]. Orv Hetil, 1999,140(30) :1681-1685 被引量：1
8[8]Cunha BA.Intravenous to oral antibiotic switch therapy[J].Drugs of Today,2001,37(5):311. 被引量：1
10[28]Cunha BA.Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community acquired pneumonia [ J ].Am J Med,2001,111(5):412. 被引量：1
